Results 81 to 90 of about 1,664 (165)

Influencing factors on selection of initial treatment dose in children diagnosed with isolated growth hormone deficiency

Trends in Pediatrics
Objective: In this study, we aimed to reveal the factors that affect the clinician’s preferences in the selection of the starting dose of growth hormone (GH) treatment.
İbrahim Mert Erbaş, Nilüfer Uyar, Özlem Nalbantoğlu, Behzat Özkan   +3 more
doaj   +1 more source

Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH

, 1997
OBJECTIVE IGF-1 and IGF binding protein (IGFBP)-3 levels in man are positively regulated by GH status; in contrast, evidence suggests an inverse relationship between GH status and IGFBP-2.
Cowan, DA, Teale, JD, Wood, PJ, Miell, JP, Kicman, AT, Laidler, P, Powrie, J, Milligan, PJ   +7 more
core   +1 more source

Somatropin

Reactions Weekly, 2006
europepmc   +3 more sources

Maintaining persistence and adherence with subcutaneous growth-hormone therapy in children: comparing jet-delivery and needle-based devices

Patient Preference and Adherence, 2014
Helen A Spoudeas,1 Priti Bajaj,2 Nathan Sommerford3 1London Centre for Paediatric Endocrinology, University College London, London, 2Ferring Pharmaceuticals, London, 3Health Informatics Research, Sciensus Ltd, Brighton, UK Purpose: Persistence and ...
Spoudeas HA, Bajaj P, Sommerford N
doaj  

A randomized controlled trial of intrauterine growth hormone for thin endometrium

Scientific Reports
Thin endometrium impairs assisted reproduction outcomes. Given the uncertain efficacy and safety profile of intrauterine Growth Hormone (GH) as a therapeutic intervention, this exploratory trial was designed to evaluate its role in treating patients with
Hatav Ghasemi Tehrani, Nastaran Zamani Dehkordi, Mohadese Hematian, Hosein Ataei-Goujani, Rahem Rahmati, Elham Naghshineh, Masoud Lotfizadeh, Ferdous Mehrabian   +7 more
doaj   +1 more source

Selective Determination of Human Growth Hormone (Somatropin) in the Presence of Its Chemical Degradation Products

, 2017
A rapid and sensitive HPLC method was developed and validated for selective determination of the human growth hormone (hGH) somatropin in the presence of its deamidated and oxidized degradation products. Reversed-phase chromatography with an acetonitrile
Mamdouh R Rezk, Faten Abdelaziz Fathalla, Marwa F Mohamed, Mostafa A Shehata   +3 more
core   +1 more source

One-Year Italian Experience with Off-Label rhGH Treatment in SHOX-Deficient Children to Overcome the Shortage of Authorized rhGH Somatropin

Endocrines
Background/Objectives: The global landscape of growth hormone (GH) therapy is increasingly affected by supply shortages, posing risks to treatment continuity, particularly in rare diseases with a single authorized GH brand. In Italy, a prolonged shortage
Laura Guazzarotti, Maria Felicia Faienza, Francesco Gallo, Rossella Gaudino, Maria Cristina Maggio, Chiara Mozzato, Gabriella Pozzobon, Mariacarolina Salerno, Malgorzata Wasniewska, Marco Cappa   +9 more
doaj   +1 more source

Frequency of the use of anabolic drugs in bodybuilding athletes in Jahrom city

فصلنامه دانشگاه علوم پزشکی جهرم, 2013
Introduction: Bodybuilding exercise is one of the most popular sports among the youth. Body builders use anabolic agents to increase their muscle growth and improve their appearance but the adverse effects of these drugs are greater than their ...
S Sobhanian, D Rajabian, F Sadeghi, E Parsayee Manesh   +3 more
doaj   +2 more sources

Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study

Endocrine Journal
Reports on long-term safety and effectiveness of daily GH replacement therapy in Japanese children with short stature due to Noonan syndrome (NS) are limited.
Koji Muroya, Masanobu Kawai, Hiroyuki Yamagishi, Takaaki Endo, Alberto Pietropoli, Jean-Marc Ferran, Reiko Horikawa   +6 more
doaj   +1 more source

Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.

, 2004
Long-term GH replacement therapy is indicated for children with growth failure due to GH deficiency (GHD). We evaluated the feasibility of administering a long-acting GH preparation [Nutropin Depot (somatropin, rDNA origin) for injectable suspension] to
Reiter, Edward, MD
core   +1 more source